In recent research, with the overexpression of the Wnt/β-catenin pathway inducing tumor progression in CRC, a key transcription factor, FOXO3a has been reported as an accelerator overexpressing its target genes through binding with β-catenin. Here, FOXO3 is linked to neoplasm.